Summary:
Summary Statement of Deficiencies D0000 An announced CLIA validation survey was conducted at Quest Diagnostics from May 30, 2024 to June 3, 2024. The laboratory was surveyed under 42 CFR Part 493 CLIA requirements. Standard deficiency cited is as follows: D6081 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(d) Each individual may direct no more than five laboratories. This STANDARD is not met as evidenced by: Based on the Centers for Medicare and Medicaid Services (CMS) Aspen website and interview, the Laboratory Director was the director of seven (#1 - #7) laboratories. Findings: Review of the CMS Aspen website, showed the Laboratory Director as being the director for seven laboratories. On 05/30/2024 at 10:40 AM, the Tampa Cytology Manager confirmed the Laboratory Director was the director of seven laboratories. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --